Zhang Qin, Lin Weiyi, Song Xiao, Li Yuli, Song Dongyu, Liu Yuzhou, Lyu Jingran, Bai Yongfang
School of Nursing and Rehabilitation, Cheeloo College of Medicine, Shandong University, Jinan, China.
Department of Oncology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China.
Psychol Health Med. 2025 Apr;30(4):818-833. doi: 10.1080/13548506.2024.2444437. Epub 2024 Dec 23.
Family resilience is critical for families recovering and growing from a cancer crisis; however, there remains a lack of universal family resilience assessment tools for families of patients with cancer. This study aimed to modify the Family Resilience Assessment Scale (FRA) and examine its psychometric properties. First, the FRA scale was modified into the Family Resilience Assessment Scale for Family Cancer (FRAS-FC) based on cultural adaptations and cancer population applicability. During the modification phase, items were deleted, added, and reclassified through expert consultation and group discussion. The language of the scale items was further optimized after the pilot study, resulting in a test version of the FRAS-FC. Subsequently, a total of 455 patients with cancer or their family caregivers from China participated in scale validation. The factor analysis showed a 6-factor structure with reasonable fit (χ/df = 2.064, RMR = 0.043, SRMR = 0.056, IFI = 0.903, CFI = 0.902, RMSEA = 0.066). Satisfactory indicators of convergent and concurrent criterion validity further supported the validity of the scale. The internal consistency was good (Cronbach's alpha = 0.939). The Pearson correlation coefficient for the test-retest sample was 0.719 ( < 0.01), reflecting the stability of the scale measures across time. The findings support the 29-item FRAS-FC as a valid and reliable tool for measuring family resilience in patients with cancer or their family caregivers. The FRAS-FC enables healthcare professionals to identify family resilience and act accordingly to fulfill the role of the family better. The modified scale can be used in a wider range of families living with cancer or be validated separately for different types of cancers. Further validation in a wider cancer population is still needed.
家庭恢复力对于家庭从癌症危机中恢复并成长至关重要；然而，对于癌症患者家庭而言，仍缺乏通用的家庭恢复力评估工具。本研究旨在修改家庭恢复力评估量表（FRA）并检验其心理测量特性。首先，基于文化适应性和癌症人群适用性，将FRA量表修改为家庭癌症恢复力评估量表（FRAS-FC）。在修改阶段，通过专家咨询和小组讨论对条目进行删除、添加和重新分类。在预试验后进一步优化了量表条目的语言，形成了FRAS-FC的测试版本。随后，来自中国的455名癌症患者或其家庭照顾者参与了量表验证。因素分析显示为六因素结构，拟合度合理（χ/df = 2.064，RMR = 0.043，SRMR = 0.056，IFI = 0.903，CFI = 0.902，RMSEA = 0.066）。令人满意的收敛效度和同时效度指标进一步支持了该量表的效度。内部一致性良好（Cronbach's alpha = 0.939）。重测样本的Pearson相关系数为0.719（<0.01），反映了量表测量在不同时间的稳定性。研究结果支持29项的FRAS-FC作为测量癌症患者或其家庭照顾者家庭恢复力的有效且可靠的工具。FRAS-FC使医疗保健专业人员能够识别家庭恢复力并据此采取行动，以更好地发挥家庭的作用。修改后的量表可用于更广泛的癌症患者家庭，或针对不同类型的癌症分别进行验证。仍需要在更广泛的癌症人群中进行进一步验证。
